Skip to main content
OpenTrials

Clinical trial condition

Breast Neoplasms

Explore clinical trials studying Breast Neoplasms. Study availability and eligibility vary by location and protocol.

9,851 public trials 1,786 recruiting studies
Refine in advanced search Browse all conditions

Breast Neoplasms trial results

Recruiting

Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA)

NCT05512364

Conditions
Breast Diseases, Breast Neoplasms, ER-positive Breast Cancer, +7 more
Locations
  • Institut Jules Bordet Anderlecht, Belgium
  • Cliniques Universitaires Saint-Luc Brussels, Belgium
  • Hopital Universitaire Brugmann Brussels, Belgium
  • Grand Hopital de Charleroi - Site Notre Dame Charleroi, Belgium
View all 111 locations
View Trial Details
Recruiting

Minimally Interventional Study on Prevalence of Emerging ESR1 Mutations in Liquid Biopsy in Three Cohorts of Patients With Breast Cancer in Comparison With Patient's Baseline ESR1 Mutation Status as Defined by Tissue Profiling.

NCT06417801

Conditions
Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
Locations
  • Ensino E Terapia de Inovação Clínica Amo - Ética Salvador, Estado de Bahia, Brazil
  • Irmandade Da Santa Casa de Misericórdia de Porto Alegre Porto Alegre, Rio Grande do Sul, Brazil
  • Fundação Antonio Prudente - A.C. Camargo Cancer Center São Paulo, Brazil
  • Instituto D'Or de Pesquisa E Ensino - São Paulo São Paulo, Brazil
View Trial Details
Recruiting

Pharmacopuncture for Aromatase Inhibitor Induced Arthralgia (AIA)

NCT07789717

Conditions
Aromatase Inhibitor, Aromatase Inhibitor Induced Arthralgia, Breast Cancer, +6 more
Locations
  • Daejeon University Daejeon Korean Medicine Hospital Daejeon, South Korea
  • Cha Ilsan Medical Center Goyang-si, Gyeonggi-do, South Korea
  • Catholic Kwandong University International St. Mary's Hospital Incheon, South Korea
View Trial Details
Recruiting

A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer

NCT03424005

Conditions
Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
Locations
  • City of Hope Duarte, California, United States
  • University of California San Diego Medical Center La Jolla, California, United States
  • Stanford Cancer Institute Stanford, California, United States
  • Rocky Mountain Cancer Center - Longmont Longmont, Colorado, United States
View all 53 locations
View Trial Details
Recruiting

Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03)

NCT06797635

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • UCLA Hematology/Oncology - Parkside ( Site 0021) Santa Monica, California, United States
  • Orchard Healthcare Research Inc. ( Site 0006) Skokie, Illinois, United States
  • Intermountain Health St. Vincent Regional Hospital - Cancer Centers of Montana ( Site 0003) Billings, Montana, United States
  • Northwest Cancer Specialists (Compass Oncology) ( Site 8003) Tigard, Oregon, United States
View all 17 locations
View Trial Details
Recruiting

Impact of Exercise on Quality of Life of EBC Patients on Treatment With Adjuvant AI With or Without CDK4/6 Inhibitors

NCT07215364

Conditions
Breast Diseases, Breast Neoplasms, Early-Stage Breast Cancer, +4 more
Locations
  • Institut Català d'Oncología (ICO) L'Hospitalet L'Hospitalet de Llobregat, Barcelona, Spain
  • Hospital Universitario de Navarra Pamplona, Navarre, Spain
  • Hospital Universitario Clínico San Cecilio Granada, Spain
  • Hospital Quirón Sagrado Corazón de Sevilla Seville, Spain
View Trial Details

Related conditions